J Gastric Cancer.  2010 Dec;10(4):206-211.

The Feasibility of Short Term Prophylactic Antibiotics in Gastric Cancer Surgery

Affiliations
  • 1Division of Gastrointestinal Surgery, Department of Surgery, The Catholic University of Korea, School of Medicine, Seoul, Korea. hmjeon@catholic.ac.kr

Abstract

PURPOSE
Most surgeons administer prophylactic antibiotics for 3 to 5 days postoperatively. However, the Center for Disease Control (CDC) guideline recommends antibiotic therapy for 24 hours or less in clean/uncontaminated surgery. Thus, we prospectively studied the use of short term prophylactic antibiotic therapy after gastric cancer surgery.
MATERIALS AND METHODS
A total of 103 patients who underwent gastric cancer surgery between October 2007 and June 2008 were prospectively enrolled in a short term prophylactic antibiotics program. One gram of cefoxitin was administered 30 minutes before the incision, and one additional gram was administered intraoperatively for cases with an operation time over 3 hours. Postoperatively, one gram was administered 3 times, every 8 hours. Patients were checked routinely for fever. All cases received open surgery, and the surgical wounds were dressed and checked for Surgical Site Infection (SSI) daily.
RESULTS
Of the 103 patients, 15 were dropped based on exclusion criteria (severe organ dysfunction, combined resection of the colon, etc). The remaining 88 patients were included in the short-term program of prophylactic antibiotic use. Of these patients, SSIs were detected in 8 (9.1%) and fever after 2 postoperative days was detected in 11 (12.5%). The incidence of SSIs increased with patient age, and postoperative fever correlated with operation time.
CONCLUSIONS
Short term prophylactic antibiotic usage is feasible in patients who undergo gastric cancer surgery, and where there are no grave comorbidities or combined resection.

Keyword

Stomach neoplasm; Antibiotic prophylaxis; Anti-bacterial agents

MeSH Terms

Anti-Bacterial Agents
Antibiotic Prophylaxis
Cefoxitin
Centers for Disease Control and Prevention (U.S.)
Colon
Comorbidity
Fever
Humans
Incidence
Prospective Studies
Stomach Neoplasms
Anti-Bacterial Agents
Cefoxitin

Figure

  • Fig. 1 Inclusion criteria and exclusion critera. 103 patients had curative gastrectomy performed. 15 patients were excluded and 88 patients were chosen. 11 patients had antibiotics therapy restarted after the initial 24 hours. 78 patients did not need additional antibiotics therapy until discharge.


Reference

1. Mayer AD, Brennan SS, Pickford IR, Evans M, Pollock AV. The prophylaxis of surgical wound infection: is cefuroxime any better than cephaloridine? J Hosp Infect. 1982. 3:143–148.
Article
3. Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan JE Jr, et al. Infectious Diseases Society of America. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994. 18:422–427.
4. Kim KH, Park CS, Chang JH, Kim NS, Lee JS, Choi BR, et al. Association between prophylactic antibiotic use and surgical site infection based on quality assessment data in Korea. J Prev Med Public Health. 2010. 43:235–244.
Article
5. Gorecki P, Schein M, Rucinski JC, Wise L. Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues. World J Surg. 1999. 23:429–432.
Article
6. Polk HC Jr, Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections. Am Surg. 2000. 66:105–111.
7. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds; Guidelines for clinical care. Arch Surg. 1993. 128:79–88.
8. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005. (3):CD001439.
Article
9. Kang SH, Kim SW, Jo IH, Hwang KS, Park SZ, Kim CD, et al. Prospective clinical study of prophylactic antibiotic therapy in nonperforated appendicitis. J Korean Surg Soc. 2000. 58:824–833.
10. Jo JH, Lee SH, Ahn BK, Baek SU. Efficacy of 24 Hour-administration of antibiotic prophylaxis after elective colorectal surgery. J Korean Surg Soc. 2008. 74:129–133.
11. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992. 13:606–608.
Article
12. Sohn BH, Lim JS, Jo DH, Kang KJ, Lim TJ. Clinical effect of an intraoperative bile culture and antibiotic prophylaxis in biliary tract surgery. J Korean Surg Soc. 1998. 54:109–116.
13. Si Y, Hur H, Kim SK, Jun KH, Chin HM, Kim W, et al. The use of short-term antimicrobial prophylaxis in elective surgery for gastric cancer. J Korean Gastric Cancer Assoc. 2008. 8:154–159.
Article
14. Walz JM, Paterson CA, Seligowski JM, Heard SO. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg. 2006. 141:1014–1018.
15. Kurz A, Sessler DI, Lenhardt R. Wound Infection and Temperature Group. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med. 1996. 334:1209–1215.
Article
16. Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med. 2000. 342:161–167.
Article
17. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001. 345:1359–1367.
Article
18. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg. 1976. 184:443–452.
Article
19. Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005. 140:174–182.
20. Wasey N, Baughan J, de Gara CJ. Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence. Can J Surg. 2003. 46:279–284.
21. Dellinger EP, Hausmann SM, Bratzler DW, Johnson RM, Daniel DM, Bunt KM, et al. Hospitals collaborate to decrease surgical site infections. Am J Surg. 2005. 190:9–15.
Article
Full Text Links
  • JGC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr